344 related articles for article (PubMed ID: 19549530)
1. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.
Oshima H; Matsunaga A; Fujimura T; Tsukamoto T; Taketo MM; Oshima M
Gastroenterology; 2006 Oct; 131(4):1086-95. PubMed ID: 17030179
[TBL] [Abstract][Full Text] [Related]
3. Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling.
Oshima H; Itadani H; Kotani H; Taketo MM; Oshima M
Cancer Res; 2009 Apr; 69(7):2729-33. PubMed ID: 19318548
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-catenin signalling regulates Sox17 expression and is essential for organizer and endoderm formation in the mouse.
Engert S; Burtscher I; Liao WP; Dulev S; Schotta G; Lickert H
Development; 2013 Aug; 140(15):3128-38. PubMed ID: 23824574
[TBL] [Abstract][Full Text] [Related]
5. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
Li JY; Han C; Zheng LL; Guo MZ
Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
[TBL] [Abstract][Full Text] [Related]
7. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
Li L; Yang WT; Zheng PS; Liu XF
Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
[TBL] [Abstract][Full Text] [Related]
8. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
9. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice.
Oshima M; Oshima H; Matsunaga A; Taketo MM
Cancer Res; 2005 Oct; 65(20):9147-51. PubMed ID: 16230370
[TBL] [Abstract][Full Text] [Related]
10. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
11. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M
J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431
[TBL] [Abstract][Full Text] [Related]
13. Identification and manipulation of biliary metaplasia in pancreatic tumors.
Delgiorno KE; Hall JC; Takeuchi KK; Pan FC; Halbrook CJ; Washington MK; Olive KP; Spence JR; Sipos B; Wright CV; Wells JM; Crawford HC
Gastroenterology; 2014 Jan; 146(1):233-44.e5. PubMed ID: 23999170
[TBL] [Abstract][Full Text] [Related]
14. Fine-Tuning of Sox17 and Canonical Wnt Coordinates the Permeability Properties of the Blood-Brain Barrier.
Corada M; Orsenigo F; Bhat GP; Conze LL; Breviario F; Cunha SI; Claesson-Welsh L; Beznoussenko GV; Mironov AA; Bacigaluppi M; Martino G; Pitulescu ME; Adams RH; Magnusson P; Dejana E
Circ Res; 2019 Feb; 124(4):511-525. PubMed ID: 30591003
[TBL] [Abstract][Full Text] [Related]
15. Sox17 modulates Wnt3A/beta-catenin-mediated transcriptional activation of the Lef-1 promoter.
Liu X; Luo M; Xie W; Wells JM; Goodheart MJ; Engelhardt JF
Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L694-710. PubMed ID: 20802155
[TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
17. SOX17 is a tumor suppressor in endometrial cancer.
Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X
Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313
[TBL] [Abstract][Full Text] [Related]
18. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
[TBL] [Abstract][Full Text] [Related]
19. SRY-box containing gene 17 regulates the Wnt/β-catenin signaling pathway in oligodendrocyte progenitor cells.
Chew LJ; Shen W; Ming X; Senatorov VV; Chen HL; Cheng Y; Hong E; Knoblach S; Gallo V
J Neurosci; 2011 Sep; 31(39):13921-35. PubMed ID: 21957254
[TBL] [Abstract][Full Text] [Related]
20. Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice.
Takasu S; Tsukamoto T; Cao XY; Toyoda T; Hirata A; Ban H; Yamamoto M; Sakai H; Yanai T; Masegi T; Oshima M; Tatematsu M
Cancer Sci; 2008 Dec; 99(12):2356-64. PubMed ID: 19018769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]